Published in
American Society for Pharmacology and Experimental Therapeutics (ASPET), Drug Metabolism and Disposition, 10(49), p. 870-881, 2021
Links
Tools
Preclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant IDH1 for Treatment of IDH1-Mutant Malignancies
Journal article published in 2021 by
Yue Chen,
Nelamangala V. Nagaraja,
Bin Fan,
Luke Utley,
Rene M. Lemieux,
Janeta Popovici-Muller,
Lenny Dang,
Hyeryun Kim,
Liping Yan,
Shin-San M. Su,
Scott A. Biller,
Hua Yang
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 